X
20
Lupin Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Trandolapril, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2009-099 - Rev 01
This Chemical Type CEP, issued on June 25, 2019, remains in force until February 13, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2245 associated with this CEP further emphasizes